Mikako Ogawa Selected Research

Mikako Ogawa Research Topics

Disease

47	Neoplasms (Cancer) 05/2022 - 01/2003
10	Atherosclerotic Plaque (Atheroma) 11/2021 - 09/2004
7	Neoplasm Metastasis (Metastasis) 03/2015 - 01/2003
5	Atherosclerosis 01/2019 - 10/2008
5	Ovarian Neoplasms (Ovarian Cancer) 03/2015 - 08/2008
4	Hypoxia (Hypoxemia) 05/2022 - 01/2014
4	Alzheimer Disease (Alzheimer's Disease) 10/2013 - 02/2006
3	Inflammation (Inflammations) 01/2017 - 11/2006
2	Lymphedema (Milroy Disease) 07/2020 - 12/2009
2	Melanoma (Melanoma, Malignant) 03/2020 - 06/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2014 - 01/2013
1	Blister (Bulla) 11/2021
1	Edema (Dropsy) 10/2021
1	Burns 02/2021
1	Cholangiocarcinoma 02/2021
1	Fibrosis (Cirrhosis) 07/2020
1	Disease Progression 07/2020
1	Rupture 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Embolism (Embolus) 01/2019
1	Lung Neoplasms (Lung Cancer) 09/2016
1	Neuroinflammatory Diseases 05/2015
1	Brain Neoplasms (Brain Tumor) 05/2015
1	Ischemia 05/2015

Drug/Important Bio-Agent (IBA)

8	Monoclonal AntibodiesIBA 11/2018 - 01/2009
7	Coloring Agents (Dyes)IBA 10/2021 - 11/2011
7	LigandsIBA 10/2021 - 03/2009
6	Fluorescent Dyes (Fluorescent Probes)IBA 01/2019 - 08/2008
5	AntibodiesIBA 10/2021 - 01/2009
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2008
5	Trastuzumab (Herceptin)FDA Link 05/2010 - 03/2009
4	silicon phthalocyanineIBA 10/2021 - 11/2018
4	Photosensitizing Agents (Photosensitizers)IBA 02/2021 - 11/2011
4	Liposomes (Liposome)IBA 01/2020 - 01/2014
4	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 10/2013 - 05/2004
4	AvidinIBA 05/2010 - 01/2009
4	Galactose (Galactopyranose)FDA LinkGeneric 02/2010 - 08/2008
3	Therapeutic UsesIBA 10/2021 - 11/2006
3	CollagenIBA 07/2020 - 10/2008
3	Glucose (Dextrose)FDA LinkGeneric 03/2020 - 02/2010
3	Pharmaceutical PreparationsIBA 02/2020 - 03/2013
3	Dendrimers (Dendrons)IBA 11/2015 - 06/2009
3	Contrast MediaIBA 11/2014 - 06/2009
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2014 - 11/2006
3	RhodaminesIBA 11/2011 - 08/2008
2	fluoromisonidazoleIBA 05/2022 - 05/2019
2	Apolipoproteins E (ApoE)IBA 11/2021 - 01/2019
2	HexokinaseIBA 03/2020 - 08/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 03/2013
2	PhosphatidylserinesIBA 01/2019 - 03/2015
2	Immunoglobulin G (IgG)IBA 01/2017 - 10/2008
2	Peptides (Polypeptides)IBA 09/2016 - 01/2003
2	Gefitinib (Iressa)FDA Link 09/2016 - 01/2013
2	Pentetic Acid (DTPA)FDA LinkGeneric 12/2014 - 11/2014
2	PolymersIBA 12/2014 - 03/2013
2	Tumor Biomarkers (Tumor Markers)IBA 10/2013 - 01/2009
2	Cholinergic Agents (Cholinergics)IBA 10/2013 - 02/2006
2	ErbB Receptors (EGF Receptor)IBA 01/2013 - 11/2011
2	Indicators and Reagents (Reagents)IBA 12/2009 - 08/2008
2	Cell Surface ReceptorsIBA 10/2008 - 11/2007
2	oxidized low density lipoproteinIBA 10/2008 - 11/2007
1	Singlet OxygenIBA 11/2021
1	ApolipoproteinsIBA 11/2021
1	AntigensIBA 10/2021
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 10/2021
1	Biological ProductsIBA 10/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 03/2020
1	Adenosine Monophosphate (AMP)IBA 03/2020
1	Immune Checkpoint InhibitorsIBA 03/2020
1	AnionsIBA 01/2020
1	Drug CarriersIBA 01/2020
1	phosphatidylserine receptorIBA 01/2019
1	Glutathione (Reduced Glutathione)IBA 01/2019
1	NitroimidazolesIBA 01/2019
1	EnzymesIBA 01/2019
1	pimonidazoleIBA 01/2019
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 08/2018
1	SolutionsIBA 04/2018
1	Cathepsin BIBA 09/2016
1	NucleophosminIBA 09/2016
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 09/2016
1	Ribosomal RNAIBA 09/2016
1	polyarginineIBA 09/2016
1	Carbon-11IBA 05/2015
1	PK 11195 (PK11195)IBA 05/2015
1	Oxidopamine (6 Hydroxydopamine)IBA 05/2015
1	GalactosidasesIBA 03/2015
1	Prostaglandins AIBA 11/2014
1	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 11/2014
1	GD3 ganglioside (GD(3))IBA 11/2014

Therapy/Procedure

16	Therapeutics 05/2022 - 11/2006
3	Immunotherapy 05/2022 - 02/2020
3	Phototherapy (Light Therapy) 11/2021 - 09/2018
2	Catheters 02/2021 - 09/2004
2	Photochemotherapy (Photodynamic Therapy) 08/2013 - 11/2011
2	Drug Therapy (Chemotherapy) 03/2013 - 11/2011
1	Aftercare (After-Treatment) 10/2021
1	Intravenous Injections 11/2014